Literature DB >> 8537490

Comparison of three methods for culture confirmation of Neisseria gonorrhoeae strains currently circulating in the UK.

A Turner1, K R Gough, A E Jephcott.   

Abstract

AIMS: To establish the current sensitivity of two commercial kits for culture confirmation of Neisseria gonorrhoeae strains circulating in the UK.
METHODS: A total of 544 strains were studied (199 gonococci from male patients attending hospitals in the county of Avon, 204 unselected N gonorrhoeae isolates from male patients in Leeds, 20 strains referred to the Gonococcus Reference Unit because of difficulties with the Syva fluorescent antibody test (FAT), and 121 strains collected over a four year period which had not reacted with serotyping antibodies). Strains were tested by sugar utilisation in cysteine trypticase base agar (CTA test), the Phadebact Monoclonal GC Test and Syva MicroTrak Neisseria gonorrhoeae Culture Confirmation Test. The auxotype and serovar of each strain were also determined.
RESULTS: The sugar utilisation test confirmed the identity of 99% (197/199) of gonococci from Avon and 97% (198/204) of those from Leeds. The Syva FAT confirmed 76% (151/199) of isolates from Avon and 84% (171/204) of those from Leeds. The Phadebact test confirmed all but one isolate from the 403 strains from both cities. Half of the 20 referred FAT negative isolates also give a negative result in the Syva FAT; however, only 10% of the remainder gave a strong reaction in our laboratory. All serotyping antibody negative strains were negative in the FAT, although all these and all of the 20 strains that give a negative result in the FAT gave positive reactions in the other culture confirmation tests. Typing tests revealed a greater diversity amongst the FAT negative strains from Leeds than those from Avon.
CONCLUSIONS: Considerable differences in the sensitivity of the MicroTrak but not with the Phadebact or CTA tests were found for the identification of isolates from two geographically distinct areas of the UK. Our results suggest that the Syva FAT would not be suitable, if used alone, for culture confirmation in Avon or Leeds.

Entities:  

Mesh:

Year:  1995        PMID: 8537490      PMCID: PMC502947          DOI: 10.1136/jcp.48.10.919

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Fluorescent-antibody-negative penicillinase-producing Neisseria gonorrhoeae.

Authors:  D T Walton
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

2.  Fluorescent monoclonal antibody test for the confirmation of Neisseria gonorrhoeae.

Authors:  A Moyes; H Young
Journal:  Med Lab Sci       Date:  1989-01

Review 3.  Laboratory methods in genitourinary medicine. Methods of diagnosing gonorrhoea.

Authors:  C A Ison
Journal:  Genitourin Med       Date:  1990-12

4.  Evaluation of two commercial procedures for rapid identification of Neisseria gonorrhoeae using a reference panel of antigenically diverse gonococci.

Authors:  D M Boehm; M Bernhardt; T A Kurzynski; D R Pennell; R F Schell
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

5.  Incidence of Neisseria gonorrhoeae isolates negative by Syva direct fluorescent-antibody test but positive by Gen-Probe accuprobe test in a sexually transmitted disease clinic population.

Authors:  J L Beebe; M P Rau; S Flageolle; B Calhoon; J S Knapp
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

6.  Auxotyping of Neisseria gonorrhoeae isolated in the United Kingdom.

Authors:  C G Copley; S I Egglestone
Journal:  J Med Microbiol       Date:  1983-08       Impact factor: 2.472

7.  Utility of monoclonal antibody coagglutination to identify Neisseria gonorrhoeae.

Authors:  H Young; A Moyes
Journal:  Genitourin Med       Date:  1989-01

8.  Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures.

Authors:  B E Laughon; J M Ehret; T T Tanino; B Van der Pol; H H Handsfield; R B Jones; F N Judson; E W Hook
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

9.  Fluorescent monoclonal antibody compared with carbohydrate utilization for rapid identification of Neisseria gonorrhoeae.

Authors:  W D Welch; G Cartwright
Journal:  J Clin Microbiol       Date:  1988-02       Impact factor: 5.948

  9 in total
  3 in total

1.  Global transmission of prolyliminopeptidase-negative Neisseria gonorrhoeae strains: implications for changes in diagnostic strategies.

Authors:  M Unemo; H M Palmer; T Blackmore; G Herrera; H Fredlund; A Limnios; N Nguyen; J Tapsall
Journal:  Sex Transm Infect       Date:  2006-08-10       Impact factor: 3.519

Review 2.  Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge.

Authors:  David M Whiley; John W Tapsall; Theo P Sloots
Journal:  J Mol Diagn       Date:  2006-02       Impact factor: 5.568

Review 3.  Microbiological diagnosis of gonorrhoea.

Authors:  A E Jephcott
Journal:  Genitourin Med       Date:  1997-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.